Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mcrC protein, E coli

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Hotspot testing for activating KRAS mutations is used in precision oncology to select colorectal cancer (CRC) patients who are… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2019
Review
2019
Therapeutic options for chemorefractory metastatic colorectal cancer (mcrc) have significantly expanded since 2009. The oral… Expand
  • figure 1
  • table I
  • table II
  • table III
Is this relevant?
Review
2018
Review
2018
Human epidermal growth factor receptor 2 (HER2) signaling pathway activation has been identified as a contributor to de novo or… Expand
  • figure 1
  • table 1
Is this relevant?
2017
2017
Please click here to see linked paper Background To investigate the potential predictors of response to regorafenib, in… Expand
Is this relevant?
2017
2017
Background TAS-102 improves overall survival (OS) in patients with metastatic colorectal cancer (mCRC) refractory to standard… Expand
Is this relevant?
2017
2017
Abstract We conducted an open-label single-arm phase II study by combining irinotecan (FOLFIRI) and bevacizumab (BV) plus… Expand
Is this relevant?
2014
2014
BackgroundMetastatic colorectal cancer (mCRC) may present various behaviours that define different courses of tumor evolution… Expand
  • figure 1
Is this relevant?
2009
2009
SummaryPurpose To determine antitumor activity of cetuximab monotherapy in patients with refractory metastatic colorectal… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2008
2008
The epidermal growth factor receptor (EGFR) is commonly expressed in colorectal cancer and is widely recognized as an important… Expand
Is this relevant?